Recent Submissions

  • Genetic data and cognitively defined late-onset Alzheimer's disease subgroups 

    Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H.; Saykin, Andrew J.; Gibbons, Laura E.; Fardo, David W.; Wessels, Madeline; Bauman, Julianna; Moore, Mackenzie; Choi, Seo-Eun; Gross, Alden L.; Rich, Joanne; Louden, Diana Nelson; Sanders, R. Elizabeth; Grabowski, Thomas J.; Bird, Thomas D.; McCurry, Susan M.; Snitz, Beth E.; Kamboh, Ilyas; Lopez, Oscar L.; De Jager, Philip L.; Bennett, David A.; Keene, C. Dirk; Larson, Eric B.; EPAD Study Group; Investigators from ACT; Investigators from ROS; Investigators from MAP; Investigators from ADNI; Investigators from the University of Pittsburgh ADRC; Crane, Paul K. (Nature, 2018-12-04)
    Categorizing people with late-onset Alzheimer's disease into biologically coherent subgroups is important for personalized medicine. We evaluated data from five studies (total n = 4050, of whom 2431 had genome-wide ...
  • Genome-wide summary statistics for cognitively defined late-onset Alzheimer’s disease subgroups 

    Unknown author (NIAGADS, 2018-12-19)
    GWAS meta-analysis summary statistics for case-control analyses of five cognitively defined Alzheimer’s disease subgroups. 1. Controls vs. memory predominant AD 2. Controls vs. visuospatial predominant AD 3. Controls ...
  • Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups 

    Mukherjee, Shubhabrata; Mez, Jesse; Trittschuh, Emily H.; Saykin, Andrew J.; Gibbons, Laura E.; Fardo, David W.; Wessels, Madeline; Bauman, Julianna; Moore, Mackenzie; Choi, Seo-Eun; Gross, Alden L.; Rich, Joanne; Louden, Diana Nelson; Sanders, R. Elizabeth; Grabowski, Thomas J.; Bird, Thomas D.; McCurry, Susan M.; Snitz, Beth E.; Kamboh, Ilyas; Lopez, Oscar L.; De Jager, Philip L.; Bennett, David A.; Keene, C. Dirk; Larson, Eric B.; EPAD Study Group; Investigators from ACT; Investigators from ROS; Investigators from MAP; Investigators from ADNI; Investigators from the University of Pittsburgh ADRC; Crane, Paul K. (Nature, 2018-12-04)
    Categorizing people with late-onset Alzheimer's disease into biologically coherent subgroups is important for personalized medicine. We evaluated data from five studies (total n = 4050, of whom 2431 had genome-wide ...